Top 5 Medical Device News Posts: July 16 to 22, 2014

medical device news logoEach week, KMC Systems brings you the top 5 medical device news articles to keep you up-to-date on the latest medical device development, design and manufacturing industry information.

In this week’s medical device news, Medtronic’s director of IT innovation gives four metrics for measuring a medical innovation department, the Abbott CEO discusses the medical company’s diagnostics product lines, Beckman Coulter acquires Siemens Healthcare Diagnostics’ clinical microbiology business and more.


Medtronic tech leader offers 4 metrics for measuring an innovation department

By Veronica Combs

Paul Thompson, director of IT innovation at Medtronic, explained how he held on for four years to bring the “hospital of the future” to life. His work is part of the company’s larger push to move from a device maker to a healthcare services provider, which he compared to IBM’s move from hardware to services.

Read more on MedCity News.


Will Abbott Rule the Diagnostics Market by 2019?

By Jamie Hartford

CEO Miles White says a strong diagnostics product pipeline will have Abbott sitting pretty in three to five years.

Read more on Medical Device and Diagnostic Industry (MDDI) Online.


Beckman Coulter to acquire Siemens Healthcare Diagnostics' clinical microbiology business

Beckman Coulter, an indirect wholly-owned subsidiary of Danaher, announced that it has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics.

Read more on Medical Devices Business Review (MDBR).


Interview with Greg King, COO of Fibralign, Winner of 2014 MedTech Innovator

By Justin Barad

Fibralign, a startup medical device company, just took home the grand prize in the 2014 MedTech Innovator competition, winning over 267 other startups.

Read more on MedGadget.


Spending on medtech innovation benefits overall U.S. economy, study shows

By Norbert Sparrow

Developing advanced medical technology and shepherding it through the regulatory process is expensive, but industry associations and lobbyists have long argued that the benefits far outweigh the costs. In fact, many contend that healthcare advances have a significant positive impact on the broader economic front. Now, the Milliken Institute has published a lengthy report that attempts to back up those claims with hard numbers. It also lays out three possible economic scenarios for the next 25 years, depending on whether R&D incentives are reduced, remain the same, or are increased.

Read more on Plastics Today.

Share your thoughts on any of these articles in the comments below.


Topics: KMC Systems, KMC, medical device news, medical device industry news, medical innovation